Author details

Full Name

Lei Bao

Affiliation

Moores Cancer Center, university of california san diego Health System

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
26938241	PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.	PLoS One	2016
25889765	GLI2 inhibition abrogates human leukemia stem cell dormancy.	J Transl Med	2015
26554380	Mutational Profiling Can Establish Clonal or Independent Origin in Synchronous Bilateral Breast and Other Tumors.	PLoS One	2015
26467658	Multipotent luminal mammary cancer stem cells model tumor heterogeneity.	Breast Cancer Res	2015
24389661	AbsCN-seq: a statistical method to estimate tumor purity, ploidy and absolute copy numbers from next-generation sequencing data.	Bioinformatics	2014
25028366	High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma.	Cancer Res	2014
24770346	Rac2 controls tumor growth, metastasis and M1-M2 macrophage differentiation in vivo.	PLoS One	2014
24914134	MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.	Blood	2014
24584817	Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1.	Tumour Biol	2014
23333150	A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.	Cell Stem Cell	2013
22421947	Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.	J Immunother	2012
22492626	Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens.	Nucleic Acids Res	2012
20820869	The detection of CMV pp65 and IE1 in glioblastoma multiforme.	J Neurooncol	2011
22185227	Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing.	Genome Biol	2011
21774984	Wilms' tumor 1-specific cytotoxic T lymphocytes can be expanded from adult donors and cord blood.	Leuk Res	2011
21626030	MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.	Cancer Immunol Immunother	2011
21708287	Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification.	J Mol Diagn	2011
21179437	Expression QTL modules as functional components underlying higher-order phenotypes.	PLoS One	2010
19034064	Infusion of cytomegalovirus specific cytotoxic T lymphocytes from a sero-negative donor can facilitate resolution of infection and immune reconstitution.	Pediatr Infect Dis J	2009
18804046	Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation.	Biol Blood Marrow Transplant	2008
18781830	Fusion of B lymphoblastoid and tumor cells expressing different antibiotic resistance genes facilitates selection of stable hybridomas.	Hybridoma (Larchmt)	2008
17663985	Interferon-gamma expressing EBV LMP2A-specific T cells for cellular immunotherapy.	Cell Immunol	2007
17589296	Rapid generation of CMV pp65-specific T cells for immunotherapy.	J Immunother	2007

1 - 23 of 23

Katie M Campbell

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 2014

Number of shared co-authors 0

Zhengming Chen

Weill Cornell Medicine and New York Presbyterian Hospital

Career Start Year 2013

Number of shared co-authors 0

Jianying Zhang

City of Hope National Medical Center

Career Start Year 2009

Number of shared co-authors 0

Benjamin G Vincent

UNC School of Medicine, The University of North Carolina at Chapel Hill

Career Start Year 2008

Number of shared co-authors 0

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 0

Tori N Yamamoto

National Cancer Institute

Career Start Year 2005

Number of shared co-authors 0

Donghui Cheng

University of California los angeles

Career Start Year 2003

Number of shared co-authors 0

Danh Tran-Thanh

Centre Hospitalier de l'Universite de Montreal

Career Start Year 2002

Number of shared co-authors 0

Kimberly R Jordan

University of Colorado Anschutz Medical Campus

Career Start Year 2002

Number of shared co-authors 0

Suchit Jhunjhunwala

Genentech Inc.

Career Start Year 2002

Number of shared co-authors 2

David J Liewehr

Center for Cancer Research

Career Start Year 1999

Number of shared co-authors 0

David M Weinstock

Merck & Co.

Career Start Year 1998

Number of shared co-authors 1

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 2

Sacha Gnjatic

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Career Start Year 1995

Number of shared co-authors 0

Zhiya Yu

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1995

Number of shared co-authors 0

Yongjin Li

Mayo Clinic

Career Start Year 1995

Number of shared co-authors 2

Claudia Rossig

University Children's Hospital Muenster

Career Start Year 1994

Number of shared co-authors 0

Timothy A Chan

Cleveland Clinic.

Career Start Year 1994

Number of shared co-authors 1

Otavia L Caballero

Ludwig Institute for Cancer Research Ltd.

Career Start Year 1993

Number of shared co-authors 0

Ping Jin

Center for Cellular Engineering, National Institutes of Health Clinical Center

Career Start Year 1993

Number of shared co-authors 0

Veena Kapoor

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 1991

Number of shared co-authors 0

Christof von Kalle

Berlin Institute of Health at Charite-Universitatsmedizin Berlin

Career Start Year 1990

Number of shared co-authors 1

Jonathan Cebon

Australia Olivia Newton-John Cancer Research Institute, La Trobe University

Career Start Year 1985

Number of shared co-authors 0

Garry P Nolan

Stanford University School of Medicine

Career Start Year 1985

Number of shared co-authors 2

Nicholas P Restifo

National Cancer Institute, National Institutes of Health (NIH)

Career Start Year 1985

Number of shared co-authors 0

Elizabeth M Jaffee

Convergence Institute, Johns Hopkins University

Career Start Year 1985

Number of shared co-authors 1

Phuong Nguyen

Hoag Memorial Hospital Presbyterian

Career Start Year 1983

Number of shared co-authors 3

Richard H Scheuermann

J. Craig Venter Institute

Career Start Year 1983

Number of shared co-authors 0

Carl H June

University of Pennsylvania Department of Pathology & Laboratory Medicine

Career Start Year 1978

Number of shared co-authors 0

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 0

row(s) 1 - 30 of 30